| Predicate | Object |
|---|---|
| rdf:type | |
| entrezgene:geneRifText |
Patients who received MLN1202 exhibited decreases in high-sensitivity C-reactive protein levels. Patients with A/G or G/G genotypes in the MCP-1 promoter had greater reductions in C-reactive protein levels than patients with the wild-type A/A genotype.
|